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The family Arenaviridae includes a number of highly pathogenic viruses that are responsible for acute
hemorrhagic fevers in humans. Genetic diversity among arenavirus species in their respective rodent hosts
supports the continued emergence of new pathogens. In the absence of available vaccines or therapeutic agents,
the hemorrhagic fever arenaviruses remain a serious public health and biodefense concern. Arenaviruses are
enveloped virions that assemble and bud from the plasma membrane. In this study, we have characterized the
microdomain organization of the virus envelope glycoprotein (GPC) on the cell surface by using immunogold
electron microscopy. We find that Junín virus (JUNV) GPC clusters into discrete microdomains of 120 to 160
nm in diameter and that this property of GPC is independent of its myristoylation and of coexpression with the
virus matrix protein Z. In cells infected with the Candid#1 strain of JUNV, and in purified Candid#1 virions,
these GPC microdomains are soluble in cold Triton X-100 detergent and are thus distinct from conventional
lipid rafts, which are utilized by numerous other viruses for assembly. Virion morphogenesis ultimately
requires colocalization of viral components, yet our dual-label immunogold staining studies failed to reveal a
spatial association of Z with GPC microdomains. This observation may reflect either rapid Z-dependent
budding of virus-like particles upon coassociation or a requirement for additional viral components in the
assembly process. Together, these results provide new insight into the molecular basis for arenavirus
morphogenesis.
The Arenaviridae are a diverse group of rodent-borne vi-
ruses, some of which are responsible for severe acute hemor-
rhagic fevers in humans. Lassa fever virus (LASV) infects as
many as 300,000 persons annually in western Africa (45), and
at least four virus species, including Junín virus (JUNV), are
recognized as causing fatal disease in the Americas. The ge-
netic diversity of arenaviruses in their respective rodent hosts
provides a vast reservoir for the continual emergence of new
viruses (1, 18). At present, there are no licensed vaccines to
prevent arenavirus infection and no effective therapies. There-
fore, the hemorrhagic fever arenaviruses remain an urgent
public health concern.
Arenaviruses are enveloped viruses, with a bisegmented
RNA genome that encodes the ambisense expression of four
proteins. The nucleoprotein (N) and the multidomain RNA-
dependent RNA polymerase (L) make up the ribonucleopro-
tein core of the virion and together are sufficient for the rep-
lication and transcription of the RNA genome (30, 35, 40). The
small matrix protein (Z) is myristoylated and associates with
the inner leaflet of the plasma membrane to drive the forma-
tion and budding of virion particles (16, 51, 65). The virus
envelope glycoprotein (GPC) is trafficked to the surfaces of
infected cells for incorporation into budding virions and me-
diates the entry of the virus into its host cell. The pathogenic
New World arenaviruses, such as JUNV, bind the host cell
transferrin receptor 1 (TfR1) through the G1 receptor-binding
subunit of GPC (1, 54), whereupon the virus is endocytosed.
The Old World arenaviruses, such as LASV and lymphocytic
choriomeningitis virus (LCMV), as well as several nonpatho-
genic New World viruses, use the cellular -dystroglycan pro-
tein for uptake into the endosome (15, 64). Fusion of the viral
and cellular membranes is activated by low pH in the maturing
endosome and is promoted by the transmembrane fusion sub-
unit of GPC (G2) (19, 71). This fusion process allows entry into
the cytosol, where viral replication and transcription ensue.
The key role of GPC in virus entry underscores its potential
as a target for antiviral intervention (9, 33, 34, 72). GPC is
synthesized as a precursor polypeptide that undergoes two
proteolytic cleavage events to form the mature envelope gly-
coprotein complex (13). The nascent polypeptide is directed to
the endoplasmic reticulum via its signal peptide, which is then
cleaved from the G1–G2 precursor by the cellular signal pep-
tidase (22, 74). Unlike conventional signal peptides, however,
the GPC signal peptide is stable and forms an essential ele-
ment of the mature complex (21, 77). The 58-amino-acid stable
signal peptide (SSP) is myristoylated and spans the membrane
twice, with both the N and C termini in the cytosol (3). Curi-
ously, the SSP can be expressed in trans and will associate with
the G1–G2 precursor to reconstitute the functional complex
(21, 77). The SSP associates with the cytoplasmic domain of
G2, likely through an intersubunit zinc finger structure (73).
Among its several roles, the SSP is required for the transit of
the complex through the Golgi apparatus (2, 21). SSP binding
masks dibasic endoplasmic reticulum retrieval motifs in the
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cytoplasmic domain of G2 to permit transport to the cell sur-
face (2). In addition, the interaction between the short ectodo-
main loop of the SSP and the ectodomain of G2 is known to
modulate pH-induced activation of GPC-mediated membrane
fusion (58, 75–77).
A second proteolytic cleavage of GPC occurs in the Golgi
apparatus to generate the mature G1 and G2 subunits (14).
This cleavage is mediated by the cellular site-1-protease/sub-
tilisin kexin isozyme 1 protease (S1P/SKI-1) and confers on the
complex the ability to promote membrane fusion (7, 32, 37,
55). The requirement for proteolytic activation is a hallmark of
the class I viral fusion proteins, which include influenza virus
hemagglutinin (HA), retrovirus Env, and GPC (24, 26, 71).
Cleavage of the G1–G2 precursor is not essential for transport
to the plasma membrane, yet only the fully mature complex is
found on virion particles (32, 37, 77). The basis for this selec-
tive incorporation into the virion is unknown. A similar segre-
gation of mature and immature glycoprotein has been reported
for human immunodeficiency virus type 1 (HIV-1) Env (20).
The processes whereby viral components are trafficked,
sorted, and assembled into virion particles are multiple and
complex (reference 60 and references therein). One organizing
principle involves the virus’s use of microdomains on the cell
surface as localized platforms for assembly. Membrane mi-
crodomains are defined as regions of a membrane containing a
membrane component (e.g., protein or lipid) at a density
higher than the average density in the membrane as a whole.
The best characterized of these microdomains are the so-called
lipid rafts, cholesterol-rich membrane domains that serve as
scaffolds for a number of cellular functions, including protein
sorting, supramolecular assembly, and signal transduction (10,
62, 63). While the term “lipid raft” likely subsumes a variety of
membrane domains, common features include their small size
(10 to 200 nm) and dynamic nature, as well as their liquid-
ordered structure that is stabilized by cholesterol and sphin-
golipids (53). The latter feature contributes to the relative
resistance of lipid rafts to solubilization in cold nonionic de-
tergents, such as Triton X-100 (TX-100) (11, 46), and thus
provides an operational definition of these difficult-to-study
lipid raft structures.
In many instances, enveloped viruses utilize these detergent-
resistant membrane microdomains (DRMs) for assembly and
budding (references 47, 50, and 60 and references therein).
Influenza virus HA, for example, is intrinsically targeted to
DRMs and from there recruits the matrix protein and other
viral components for morphogenesis (17, 59, 78). Lipid rafts
are also implicated in the life cycles of HIV-1 (49), paramyxo-
viruses (4, 43), and filoviruses (6). In contrast, the G glyco-
protein of vesicular stomatitis virus (VSV) is excluded from
DRMs (29, 70, 78) but nonetheless assembles into distinct
microdomains on the cell surface (12, 67).
The membrane requirements for arenavirus assembly have
not been examined in detail, but several considerations suggest
that lipid rafts might be involved. The fact that the arenavirus
Z and GPC proteins are both myristoylated raises the possi-
bility that they may cotraffic to specific membrane domains for
assembly. In many instances, protein acylation is critical for
association with lipid rafts (39, 46), and this may be the case
for these arenavirus proteins. The matrix protein Z, for exam-
ple, fails to associate with the plasma membrane in the absence
of myristoylation (16, 66). Furthermore, the nonmyristoylated
G2A mutant of GPC is trafficked to and accumulates on the
cell surface, but there it suffers a major deficiency in membrane
fusion activity (58, 77). This fusion defect is similar to that
reported for a mutant of influenza virus HA that fails to asso-
ciate with lipid rafts (68). The reduced fusion activity of the
mutant HA is attributed to its relatively sparse density in lipid
rafts, on which virus particles are assembled (68).
We have investigated whether arenaviruses utilize lipid rafts
for assembly. By using cold-detergent extraction and electron
microscopy, we find that the mature JUNV GPC complex does
not fractionate with DRMs yet assembles on the cell surface
into nonraft microdomains that measure 120 to 160 nm. GPC
clustering is independent of N-terminal myristoylation in the
SSP. Interestingly, Z does not colocalize with GPC microdo-
mains in cotransfected cells, suggesting that additional signals
may operate in virus-infected cells to recruit viral components
to GPC microdomains for assembly and budding.
MATERIALS AND METHODS
Molecular and viral reagents. The GPC cDNA from the pathogenic JUNV
strain MC2 (27) was introduced into Vero cells by Lipofectamine 2000 (Invitro-
gen)-mediated transfection of a pcDNA3.1-based (Invitrogen) plasmid (77).
Expression was driven by the bacteriophage T7 promoter in the vector, and T7
RNA polymerase was provided by concomitant infection with the recombinant
vaccinia virus vTF7-3 (25, 77). The attenuated Candid#1 strain of JUNV (5, 42)
was provided by Robert Tesh (WHO Reference Center for Arboviruses) and was
propagated in Vero cells. The Z protein cDNA from the Candid#1 virus (28)
was kindly provided by Victor Romanowski (National University of La Plata, La
Plata, Argentina) and was subsequently engineered to encode a C-terminal S
peptide (Spep) tag (31, 77). The GPC and Z proteins of MC2 and Candid#1 are
essentially identical, each containing two conservative amino acid substitutions
among 485 and 94 residues, respectively.
The G1-directed monoclonal antibody (MAb) BE08 (57) was obtained from
the NIH Biodefense and Emerging Infections Research Resources Repository.
The G2-directed MAb F106G3 was generated against an Escherichia coli-ex-
pressed JUNV G2 ectodomain protein and was provided by Jody D. Berry, Ute
Ströher, and Heinz Feldmann (National Microbiology Laboratory, Winnipeg,
Canada). Biotinylated S protein was purchased from Novagen (Madison, WI).
Streptavidin and secondary antibodies (Fab fragments) conjugated to Alexa
Fluor (AF), and the Vibrant lipid raft labeling kit containing AF555-conjugated
cholera toxin subunit B (CTB) and anti-CTB rabbit serum, were purchased from
Molecular Probes (Eugene, OR). A goat anti-mouse immunoglobulin antibody
conjugated with 12-nm-diameter colloidal gold particles was purchased from
Jackson ImmunoResearch (West Grove, PA), and streptavidin conjugated with
6-nm-diameter colloidal gold particles was purchased from Electron Microscopy
Sciences (Hatfield, PA).
Confocal microscopy. Vero cells were infected with vTF7-3 and transfected
with plasmids encoding JUNV GPC or Z on chambered coverglasses (Lab-Tek
II) as previously described (3). The cultures were maintained in a medium
containing 10 M cytosine arabinoside to prevent vaccinia virus replication and
were used for immunolabeling 6 h postinfection to minimize cytopathic effect.
Cells were fixed for 1 h in cold 2% formaldehyde in phosphate-buffered saline
(PBS) prior to incubation with AF555-conjugated CTB in PBS containing 5%
fetal bovine serum (FBS). In many studies, live cells were stained with AF555-
conjugated CTB and subsequently incubated with a rabbit antiserum against
CTB in order to patch lipid rafts. Following fixation, reactive formaldehyde was
quenched in the cold using 50 mM Tris HCl (pH 7.4). Further incubations with
the anti-G1 specific MAb BE08 and the AF488-conjugated secondary goat anti-
mouse immunoglobulin G Fab fragment were carried out in cold PBS containing
5% FBS, and ultimately in cold PBS. Slow Fade Gold (Molecular Probes) was
used to limit photobleaching. In control studies, the distribution of GPC on the
cell surface was similar when formaldehyde-fixed cells were permeabilized prior
to incubation with MAb BE08 (see below). Thus, it is likely that the native
membrane distribution of GPC is stabilized by formaldehyde fixation.
To examine cultures infected with the Candid#1 strain of JUNV, infected
Vero cells were plated onto chambered coverslips 4 days postinfection and were
subsequently incubated with AF555-conjugated CTB and anti-CTB antiserum,
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fixed in cold 2% formaldehyde, and labeled with anti-G1 MAb BE08 and the
AF488-conjugated secondary Fab. Labeling was visualized using an inverted
Nikon TE-300 microscope and a Bio-Rad Radiance 2000 confocal laser scanning
microscopy system. Images were merged using Lasersharp software (Bio-Rad).
Membrane fractionation. Vero cells infected with Candid#1 virus were solu-
bilized in cold PBS lysis buffer containing 1 mM EDTA, 1 mM EGTA, and 1%
TX-100 (44). Cells were incubated on ice for 1 h with occasional mixing to ensure
complete segregation of soluble and insoluble membranes. Ten percent of this
crude lysate was reserved and treated with Benzonase nuclease (Novagen) for
subsequent analysis. The remainder was subjected to high-speed centrifugation
(21,000  g for 10 min at 4°C) in order to pellet DRMs. These were subsequently
resuspended in cold PBS lysis buffer, and 10% was reserved and treated with
Benzonase for 30 min on ice. The 10% aliquots of the crude lysate and DRMs,
as well as 10% of the detergent-soluble cleared supernatant, were subjected to
peptide-N-glycosidase F (PNGase F; New England Biolabs) digestion to improve
antigenicity in the subsequent Western blot analysis. Deglycosylated polypep-
tides were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) under reducing conditions (NuPAGE 4 to 12% Bis-Tris gel with
morpholineethanesulfonic acid running buffer; Invitrogen) and were transferred
to a nitrocellulose membrane (Invitrogen). The membrane was treated in Tris
HCl-buffered saline containing 0.1% Tween 20 and 5% dry milk and was probed
using the G2-directed MAb F106G3. Signal was detected with a horseradish
peroxidase-conjugated anti-mouse immunoglobulin antibody (Cappel) and
SuperSignal West Pico chemiluminescence (Pierce). Using these methods (44),
the cellular proteins caveolin and TfR segregate appropriately into detergent-
insoluble and detergent-soluble fractions, respectively.
Candid#1 virions were purified by ultracentrifugation through a 20% sucrose
cushion and were solubilized in cold PBS lysis buffer (containing 1 mM EDTA,
1 mM EGTA, and 1% TX-100). Half of the crude lysate was treated with
Benzonase, while the other half was subjected to high-speed centrifugation in
order to isolate DRMs, which were then resuspended and treated with Benzo-
nase. The crude lysate, DRMs, and high-speed supernatant were treated with
PNGase F, and the polypeptides were resolved by SDS-PAGE and subjected to
Western blot analysis using the G2-directed MAb F106G3.
Density gradient analysis of DRMs. Vero cells infected with Candid#1 virus
were solubilized in cold PBS lysis buffer, and the crude lysate was cleared by
high-speed centrifugation. Aliquots of both the crude lysate and the detergent-
soluble supernatant were reserved as before for subsequent analysis. The deter-
gent-insoluble membranes were resuspended in cold buffer B (38 mM each of the
potassium salts of aspartic acid, glutamic acid, and gluconic acid, 20 mM mor-
pholinepropanesulfonic acid [MOPS; pH 7.1], 10 mM potassium bicarbonate, 0.5
mM magnesium carbonate, 1 mM EDTA, 1 mM EGTA) also containing pro-
tease, phosphatase inhibitors, and glutathione (44) and were adjusted to 1%
TX-100. This suspension was treated with Benzonase for 30 min on ice, adjusted
to 49% OptiPrep (Sigma) using a 60% OptiPrep stock solution, and subjected to
flotation equilibrium density gradient centrifugation (44). Five hundred micro-
liters was placed in a polyallomer ultracentrifuge tube and overlaid with a
gradient of 48 to 15% OptiPrep in cold buffer B (without TX-100). Samples were
centrifuged to equilibrium using an SW55 Ti rotor (100,000  g for 18 h at 4°C),
and fractions of 200 l each were manually collected from the bottom of the
tube. The refractive indices of the fractions were determined and used to calcu-
late the respective densities (44). Proteins were concentrated by overnight pre-
cipitation in 10% cold trichloroacetic acid and were collected by high-speed
centrifugation. These pellets were washed in cold acetone, air dried, solubilized
in 50 l of 7 M urea sample buffer (7 M urea, 125 mM Tris HCl [pH 6.95], 2%
SDS, 0.1 mM dithiothreitol, 1 mM EDTA, 0.1% bromophenol blue), and heated
to 55°C for 15 min. Samples were resolved by SDS-PAGE (10% Bis-Tris gel) and
transferred to nitrocellulose membranes as previously described (44). GPC was
detected using the G2-directed MAb F106G3. In parallel gradients, an antibody
directed to caveolin 1 (Abcam Technologies, Cambridge, MA) was used to
identify fractions containing caveolae and lipid rafts. An antibody specific for
TfR was purchased from Chemicon (Temecula, CA).
Electron microscopy analysis. Vero cells expressing recombinant wild-type or
G2A GPC were fixed with 2% cold formaldehyde and treated on ice with 5 g/ml
of digitonin in cytoplasmic buffer (20 mM HEPES [pH 7.3], 110 mM potassium
acetate, 5 mM sodium chloride, 2 mM magnesium chloride, and 5 mM EGTA)
for 20 min to selectively permeabilize the plasma membrane (3). Cells were then
incubated in cytoplasmic buffer containing 5% dialyzed FBS, followed by the
G1-specific MAb BE08 and a secondary antibody conjugated to 12-nm-diameter
gold particles. Cells were then scraped, fixed in 2.5% glutaraldehyde, and pro-
cessed for electron microscopy as previously described (12). Thin sections were
lightly stained in order to better visualize gold particles. Negative controls in-
cluded mock-transfected cells, in which no immunoreactivity could be detected.
For double labeling of Z and GPC, GPC was again visualized with anti-G1
antibody and 12-nm-diameter gold particles, while Z was detected using biotin-
ylated S protein (Novagen), which binds an Spep affinity tag (31) appended to the
C terminus of Z, and streptavidin conjugated to 6-nm-diameter gold particles.
Thin sections were scanned at low magnification to identify transfected cells that
had positive immunoreactivity, and arbitrary regions of plasma membrane were
imaged at high magnification (43,000). Micrographs from 25 individual cells
were collected, digitized, and analyzed for the distribution of gold particles as
described previously (12).
RESULTS
Confocal microscopy reveals GPC clustering on the cell
surface. Our observation that myristoylation of the SSP is
important for GPC-mediated membrane fusion led us to hy-
pothesize that lipid rafts might play a role in arenavirus assem-
bly (76). We thus sought to determine the distribution of GPC
on the plasma membrane and its relationship to lipid raft
microdomains by confocal microscopy. Vero cells expressing
wild-type GPC were fixed in cold 2% formaldehyde and incu-
bated with a G1-specific MAb (BE08 [57]) and an AF488-
conjugated secondary antibody. Lipid rafts were in turn iden-
tified using AF555-conjugated CTB, which binds to the
raft-associated GM1 ganglioside. At the level of resolution of
confocal microscopy, GPC staining appeared as a green “string
of beads” along the cell surface (Fig. 1A, left), consistent with
GPC clustering into membrane microdomains. CTB staining
(red) was largely continuous throughout the plasma membrane
(Fig. 1A, center) due to the widespread distribution of submi-
croscopic lipid rafts, and thus the GPC “beads” appeared pre-
dominantly yellow in the merged images (Fig. 1A, right). With-
out being able to distinguish individual lipid rafts, we could not
use the overlay of GPC and CTB signals to infer the localiza-
tion of GPC within lipid rafts.
In order to resolve discrete lipid rafts, we used rabbit anti-
CTB serum to cross-link individual rafts in order to form larger
patches (29). The cells were then fixed and stained for GPC as
described above. If GPC is raft associated, it should patch with
lipid rafts and appear yellow in the merged images. GPC that
is not associated with these lipid rafts would appear green in
the remaining membrane. While CTB cross-linking allowed us
to form some discrete lipid raft patches (Fig. 1B, center), much
of the cell surface remained densely labeled. In these unre-
solved regions of the membrane, the GPC clusters remained
yellow and uninformative (Fig. 1B, right). Importantly, how-
ever, the visible patching of lipid rafts in other regions of the
membrane now allowed us to detect multiple instances in
which GPC clusters remained green. By aggregating rafts into
distinct patches, we exposed GPC clusters that did not colo-
calize with CTB staining, suggesting that at least some GPC
may not be associated with lipid raft microdomains.
GPC clusters on the surfaces of Candid#1-infected cells. To
determine the relevance of GPC clustering in viral infection,
we examined expression in cells infected with the attenuated
Candid#1 strain of JUNV (5, 42). In these experiments, live
cells were first incubated in the cold with AF555-conjugated
CTB and rabbit anti-CTB antiserum in order to patch lipid
rafts; then they were fixed and labeled with a G1-specific an-
tibody. Infected cells comprised 10% of the culture and dis-
played large amounts of GPC on their surfaces (Fig. 1C, left).
In many cases, this prevented the detection of discrete clusters.
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Nonetheless, regions containing lesser amounts of GPC
showed individual clusters spread across the cell surface, com-
parable to the “string-of-beads” appearance in cells expressing
recombinant GPC. In these regions, overlap with CTB patches
for the most part remained, although clear islands of green
fluorescence were also visible (Fig. 1C, right). Taken together,
confocal microscopy studies of the cell surface distribution of
GPC in virus-infected and recombinant GPC-expressing cells
indicated that GPC intrinsically forms discrete clusters on the
cell surface. This tendency to cluster did not require other viral
proteins or virus infection.
GPC is not associated with detergent-resistant lipid rafts in
virus-infected cells. To further explore the relationship be-
tween GPC clusters and rafts, we turned to the biochemical
definition of lipid rafts as DRMs (53). Specifically, we exam-
ined the partitioning of GPC from Candid#1-infected cells
into detergent-soluble and detergent-insoluble membranes.
Cells were disrupted in cold buffer containing 1% TX-100, and
lysates were subjected to high-speed centrifugation in order to
generate soluble and pelleted membrane fractions. Equivalent
aliquots (10%) of each fraction were incubated with PNGase F
to generate deglycosylated polypeptides (77). This treatment
was found to enhance detection by the G2-specific MAb
F106G3 in Western blot analysis, which was used to determine
the distribution of GPC. As shown in Fig. 2A, the vast majority
of the GPC in Candid#1-infected cells, and all of the mature
complex, was found in the detergent-soluble lysate. Only a
trace of the uncleaved G1–G2 precursor was evident in the
pelleted, detergent-insoluble membrane fraction.
This finding was corroborated by studies in which the deter-
gent-insoluble membranes from Candid#1 virus-infected cells
were resuspended in a buffer containing 1% TX-100, and equi-
FIG. 1. Confocal microscopic analysis of GPC distribution on the cell surface. Intact cells either expressing wild-type GPC (A and B) or the
nonmyristoylated G2A mutant (D) or infected with Candid#1 virus (C) were stained with CTB (red) to visualize lipid rafts and with the G1-specific
MAb BE08 (green). In panels B through D, bound CTB was cross-linked using a rabbit antiserum to induce patching of lipid rafts prior to fixation
and incubation with MAb BE08. The cells are displayed as green (left), red (center), and merged (right) images. Three representative micrographs
are shown in each panel in order to illustrate the variability in the appearance of the GPC “string of beads” and the limitations in resolving isolated
GPC and CTB-labeled lipid raft regions.
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librium density gradient ultracentrifugation was performed to
float intact membranes. In this manner, we sought to purify
and concentrate detergent-insoluble membranes in order to
further confirm the absence of GPC in lipid rafts, and to
provide a positive control for the isolation of lipid rafts by
analyzing gradient fractions for the lipid raft marker caveolin.
Following ultracentrifugation, the gradients were fractionated,
and each fraction was treated with PNGase F and subjected to
Western blot analysis. In parallel gradients, caveolin was de-
tected in fractions whose density corresponded to that of lipid
rafts (Fig. 2C, bottom). However, no GPC was found in these
or any other detergent-resistant membrane-containing frac-
tions (Fig. 2C, top). These findings extend those from our
microscopy studies and indicate that GPC does not associate
appreciably with lipid rafts.
Cell membranes are dynamic, and raft structures may be
transient, so we wanted to determine whether the Candid#1
virion itself contained a detergent-resistant membrane. Virions
from the cell culture supernatant were first purified by ultra-
centrifugation through a 20% sucrose pad and then disrupted
in cold buffer containing 1% TX-100. Detergent-insoluble
membranes were isolated by high-speed centrifugation, and
soluble and pelleted fractions were treated with PNGase F and
subjected to Western blot analysis using the G2-specific MAb
F106G3 (Fig. 2B). No GPC was detected in the detergent-
insoluble membranes, and all the virion GPC was in the solu-
ble-membrane fraction. In contrast to the infected cells (ex-
amples in Fig. 2A and C), the uncleaved G1–G2 precursor was
excluded from virus particles (32, 37, 77).
GPC clustering does not require myristoylation. The studies
described above suggest that detergent-resistant lipid rafts are
not involved in GPC localization on the cell surface. Nonethe-
less, confocal microscopy clearly shows a “string-of-beads” dis-
tribution, consistent with some form of clustering. We were
therefore interested in determining whether this pattern might
be dependent on GPC myristoylation. Cells expressing the
nonmyristoylated G2A mutant were examined by confocal
microscopy and showed a beaded distribution of GPC sim-
FIG. 2. GPC segregates with the TX-100-soluble membrane in Candid#1-infected cells and virions. (A) Cells infected with Candid#1 were
lysed in cold buffer containing 1% TX-100, and insoluble membranes were separated by high-speed centrifugation. Equal aliquots of the total lysate
as well as of the high-speed supernatant (soluble) and the insoluble membrane pellet were incubated with PNGase F and subjected to Western
blot analysis using the G2-specific MAb F106G3. Appropriate segregation of detergent-soluble (TfR) and detergent-insoluble (caveolin) cell
markers was confirmed in other studies. (B) Candid#1 virions were purified from the cell culture medium by ultracentrifugation through a buffer
containing 20% sucrose and were lysed in cold buffer containing 1% TX-100. Equal aliquots of the virion lysate and the detergent-soluble and
-insoluble membrane fractions were deglycosylated and analyzed as described for panel A. The G1–G2 precursor and the mature G2 subunit are
indicated. Incomplete deglycosylation products from cell lysates are also visible. (C) (Top) The detergent-insoluble fraction from cell lysates
prepared as described for panel A was resuspended in TX-100-containing lysis buffer and subjected to OptiPrep density gradient ultracentrifu-
gation in order to float detergent-resistant membranes. Fractions from the resulting gradient (left), as well as aliquots of the total-cell lysate and
the high-speed supernatant containing detergent-soluble membranes (right), were analyzed as described for panel A. The positions of G2 and the
G1–G2 precursor are indicated. (Bottom) Caveolin-containing lipid rafts were detected in parallel gradients by Western blot analysis. Buoyant
densities calculated from the refractive indices of fractions (44) are plotted along the horizontal axes to standardize individual gradients.
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ilar to that of the wild type (Fig. 1D, left). At this level of
resolution, myristoylation was not required for directing
GPC to distinct clusters on the cell surface. As with the wild
type, cross-linking with CTB allowed the resolution of oc-
casional G2A GPC clusters that were not associated with
lipid rafts (Fig. 1D, right).
Electron microscopy demonstrates the presence of GPC in
membrane microdomains. Because the size of typical mem-
brane microdomains is at or below the limit of resolution of
confocal microscopy (200 nm), we further analyzed the dis-
tribution of GPC on the cell surface by using immunogold
electron microscopy. Vero cells expressing recombinant GPC
were fixed, permeabilized with 5 g/ml of digitonin (as part of
subsequent studies, described below), and incubated with the
G1-specific MAb BE08 and a secondary antibody conjugated
to 12-nm-diameter gold particles. Digitonin selectively solubi-
lizes the plasma membrane, leaving intracellular membrane
structures intact. The anti-G1 antibody thus binds only on the
cell surface, since intracellular G1 is luminal and is not acces-
sible (3). Cells were then scraped, fixed in 2.5% glutaralde-
hyde, and processed for electron microscopy as previously de-
scribed (12). Plasma membrane-containing regions of 25
individual transfected cells were arbitrarily chosen for analysis.
A representative micrograph of GPC labeling is shown in Fig.
3A. Labeling was often observed to occur in clusters of three to
eight gold particles, supporting the notion that GPC is orga-
nized into discrete membrane microdomains. In many micro-
graphs, the GPC clusters showed outward curvature of the
membrane and a thickening of the underlying structure (Fig.
3A), features reminiscent of nascent budding domains. These
images were surprising in that the virus matrix protein Z, which
is sufficient for the budding of virus-like particles (51, 65), was
not expressed in these cells. These structures suggest that GPC
may itself contribute to membrane curvature in support of
virion budding.
The extent of GPC clustering on the plasma membrane was
quantified from digitized images by analyzing the distribution
of interparticle distances (12). Briefly, distances between all
pairs of gold particles were measured along the trace of the
plasma membrane, collected into 20-nm increments, and plot-
ted as a histogram with the distance of separation on the x axis
and the number of particles in each 20-nm increment of dis-
tance on the y axis. The y axis values were further normalized
for the number of particles analyzed in order to yield a nor-
malized particle density. This histogram was used to determine
whether interparticle distances were randomly distributed or
grouped around short, raft-like dimensions (12).
Normalized particle densities for GPC are plotted in Fig. 3B
and were maximal for short distances of separation (21 to 40
nm), indicating that GPC is organized in clusters. The normal-
ized density was reduced at lower distances of separation (1 to
20 nm) because one 12-nm-diameter gold particle, which has a
“halo” of bound protein, can interfere with the binding of
another gold particle within this distance. This interference
phenomenon implies that each gold cluster includes multiple
oligomeric envelope spikes, which are known to be separated
by 10 nm on the virion surface (48). As interparticle distances
increased beyond 40 nm, the normalized density declined to
that predicted for a random distribution of particles (Fig. 3B).
By extrapolating the steep decline in particle density beyond 40
FIG. 3. Analysis of wild-type and G2A GPC distribution in plasma
membrane microdomains. Vero cells were transfected with plasmids
encoding wild-type (A and B) or G2A (C and D) GPC and were
subsequently fixed, permeabilized, and labeled with mouse anti-G1
MAb BE08 followed by a goat anti-mouse immunoglobulin G Fab
fragment conjugated with 12-nm-diameter colloidal gold particles. (A
and C) Representative electron micrographs. Arrows indicate clusters
of 12-nm-diameter gold particles. Arrowheads indicate examples of
outward curvature of the membrane containing GPC. Bars, 100 nm. (B
and D) Pairwise distances between all particles in 25 micrographs were
calculated from the collected measurements of distances between par-
ticles along the trace of the plasma membrane. The density was de-
termined as the number of gold particles in each 20-nm increment,
normalized to the total number of particles analyzed. The normalized
density of particles per 20 nm was plotted on the y axis against the
distance between particles on the x axis in a histogram. The average
size of the membrane microdomains was estimated as the x intercept
(vertical solid line) where the extrapolated slope intersects the average
density of GPC in the plasma membrane (horizontal dashed line).
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nm to the calculated random density (solid lines), we can
approximate the average dimension of the GPC microdomains
as 120 to 160 nm. This size is similar to the dimensions de-
scribed for microdomains of the VSV G glycoprotein (100 to
150 nm) (12) and smaller than those of the influenza virus HA
(325 to 500 nm) (38).
We had previously speculated that the significant fusion
deficiency in the G2A mutant of GPC might result from its
inability to concentrate in specific membrane microdomains
and thereby to cooperate with adjacent envelope spikes for
efficient membrane fusion (77). To investigate this hypothesis,
we examined the distribution of the nonmyristoylated mutant
on the cell surface. As shown in Fig. 3C and D, G2A GPC
retained the ability to cluster on the plasma membrane. In-
deed, the maximal particle density, a measure of the tendency
to cluster, and the extrapolated diameter of the G2A GPC
microdomains (140 to 160 nm) were remarkably similar to
those of the wild type. Membrane structures consistent with
nascent budding domains were also observed. Thus, myristoyl-
ation of the SSP is not required for GPC assembly into mem-
brane microdomains; clustering appears to be an intrinsic
property of the GPC protein. Furthermore, the reduced effi-
ciency of cell-cell fusion by the G2A mutant does not appear to
be related to differences in the distribution of GPC on the
plasma membrane (77).
Coexpression of Z does not alter GPC clustering. Expression
of the matrix protein Z is sufficient for the assembly and bud-
ding of virus-like particles (51, 65), and coexpression with GPC
and other viral components in reverse-genetic systems gives
rise to virions capable of GPC-mediated entry into target cells
(36; S. S. Agnihothram and J. H. Nunberg, unpublished data).
Recent evidence suggests that the Z and GPC proteins interact
directly in virion assembly (16, 48). We therefore wanted to
investigate whether the distribution of GPC on the plasma
membrane might be affected by coexpression of Z. In these
studies, GPC was again visualized with an anti-G1 antibody
labeled with 12-nm-diameter gold particles, and because no
specific antibodies directed to Z are available, coexpression of
the matrix protein was detected using an Spep affinity tag (31)
appended to the C terminus of Z. This construct had been
shown to support the budding of virus-like particles when co-
expressed with GPC (J. York and S. S. Agnihothram, unpub-
lished data), and analogously tagged Z proteins have been
used successfully in reverse-genetic studies with LCMV (52).
Cotransfected cells were fixed with formaldehyde, and the
plasma membranes were selectively permeabilized using digi-
tonin (3) in order to allow the biotinylated S protein (Novagen)
to access the cytosolic Spep tag. The Z protein was detected by
electron microscopy using streptavidin conjugated to 6-nm-
diameter gold particles.
Figure 4A shows a representative electron micrograph of
dual-labeled cells. GPC, labeled with 12-nm-diameter gold
particles, was distributed in small clusters similar to those in
the absence of Z (Fig. 3A). The Z protein, labeled with 6-nm-
diameter gold particles, was distributed throughout the cyto-
plasm of transfected cells but appeared to be concentrated
near the plasma membrane. This perimembrane localization of
Z was also noted upon labeling of the same cells for confocal
microscopy (Agnihothram and Nunberg, unpublished) and
upon expression of the LCMV Z protein (16), but not in the
case of LASV (23). Six-nanometer-diameter gold particles
within 30 nm of the trace of the plasma membrane were judged
to be associated with the membrane itself (12, 67). For exam-
ple, the 6-nm-diameter gold particles labeled a to e in Fig. 4A
FIG. 4. Analysis of the organization of GPC in the presence of Z.
Vero cells were cotransfected with plasmids encoding GPC and Spep-
tagged Z. Cells were fixed, permeabilized, and double-labeled first with
the mouse anti-G1 MAb BE08 and biotinylated S protein and then with
a secondary antibody conjugated with 12-nm-diameter colloidal gold par-
ticles and streptavidin conjugated with 6-nm-diameter colloidal gold par-
ticles. (A) Representative electron micrograph of cells double-labeled for
GPC and Z. The arrow indicates a cluster of 12-nm-diameter gold parti-
cles, and the letters a to e indicate 6-nm-diameter gold particles within 30
nm of the trace of the plasma membrane, which were judged to be
associated with the membrane itself. Bar, 100 nm. (B) Pairwise distances
between all 12-nm-diameter gold particles (GPC), analyzed as described
for Fig. 3. (C) Measurements were collected between each 6-nm-diameter
gold particle (Z) within 30 nm of the trace of the plasma membrane and
every 12-nm-diameter gold particle (GPC). The density was calculated as
the number of 12-nm-diameter gold particles in 20-nm distance incre-
ments from each 6-nm-diameter gold particle and was normalized to the
number of gold particles analyzed. The normalized density of 12-nm-
diameter particles/20 nm was plotted on the y axis against the distance
from the 6-nm-diameter particles on the x axis in a histogram. The average
density of GPC labeling in the plasma membrane is indicated by the
horizontal dashed line.
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are considered to associate with the plasma membrane. Elec-
tron micrographs from 25 individual cells expressing both GPC
and Z were quantified in order to determine the distribution of
gold particles on the plasma membrane. As shown in Fig. 4B,
the overall clustering of GPC was largely unchanged by the
coexpression of Z. The average dimensions of the GPC mi-
crodomains (130 to 160 nm) were identical to those in the
absence of Z.
Z does not colocalize with GPC microdomains. The intrinsic
property of GPC to cluster into discrete microdomains raised
the possibility that Z may be recruited to GPC microdomains
for virion assembly. To test this hypothesis, we determined the
distribution of distances from every 6-nm gold particle (Z) to
every 12-nm particle (GPC) in the 25 micrographs. Colocal-
ization would be indicated by a tendency of Z and GPC gold
particles to be in close proximity, as indicated by a high nor-
malized density of 12-nm-diameter particles within short dis-
tances of separation from 6-nm-diameter particles. This anal-
ysis, however, revealed only a random distribution of GPC
relative to Z (Fig. 4C). Despite the requirement that Z and
GPC ultimately coassemble to generate infectious virions, we
found no evidence for colocalization in the present studies.
DISCUSSION
Virus assembly necessarily includes colocalization of virion
structural components at the site of virus budding. For many
enveloped viruses, specialized membrane microdomains called
lipid rafts provide a physical platform for this process (refer-
ences 47, 50, and 60 and references therein). These cholester-
ol-rich and liquid-ordered membrane structures range in size
from 10 to 200 nm on the plasma membrane and are often
characterized by their resistance to solubilization in cold non-
ionic detergents. We have used this biochemical property of
lipid rafts to demonstrate that the arenavirus envelope glyco-
protein GPC does not associate with DRMs in cells infected
with the Candid#1 strain of JUNV. All the GPC protein in the
infected cells, as well as in purified Candid#1 virions, is solu-
bilized by extraction in cold 1% TX-100 detergent. Nonethe-
less, by using quantitative immunogold electron microscopy,
we have shown that GPC does indeed assemble into discrete
microdomains of 120 to 160 nm on the plasma membrane.
Several lines of evidence had suggested that lipid rafts play
a role in arenavirus assembly. First, depletion of cellular cho-
lesterol by methyl--cyclodextrin has been reported to inhibit
arenavirus replication (61, 69), and because the arenavirus
receptors TfR1 and -dystroglycan (15, 54, 64) do not them-
selves associate with lipid rafts, we surmised that the require-
ment for cholesterol might arise in virus egress. Second, my-
ristoylation is essential for both GPC and the Z matrix protein
(52, 77), and the addition of a saturated fatty acid moiety in
raft proteins is often required for association (39, 46). How-
ever, the myristoylated wild-type JUNV GPC is clearly not
associated with lipid rafts. Indeed, we show that myristoylation
is dispensable for GPC clustering into nonraft membrane mi-
crodomains. The cell surface microdomains formed by the
nonmyristoylated G2A mutant of GPC are indistinguishable
from those of the wild type. Therefore, the ability of the arena-
virus GPC to localize to discrete, and presumably specialized,
membrane microdomains is independent of myristate addition
to the SSP.
We report that GPC does not utilize cholesterol-rich lipid
rafts as the basis for its assembly into membrane microdo-
mains. This finding distinguishes the arenaviruses from the
many enveloped viruses that do require DRMs for virion mor-
phogenesis, e.g., influenza virus, HIV-1, paramyxoviruses, and
filoviruses (references 47, 50, and 60 and references therein).
In this regard, GPC is similar to the well-studied G glycopro-
tein of VSV, which is likewise excluded from DRMs (29, 70,
78) and utilizes detergent-soluble membrane microdomains as
a platform for assembly (12, 67). The significance of this dis-
tinction between membrane sites for virion assembly is cur-
rently unclear. Indeed, the difference between detergent-resis-
tant and detergent-soluble membrane microdomains may
reflect quantitative rather than qualitative differences in lipid
composition. Although VSV serves as the prototype for viruses
that utilize nonraft microdomains for assembly, its envelope is
nonetheless enriched in sphingomyelin and cholesterol (41).
We and others have previously shown that the membrane
fusion activity of the nonmyristoylated G2A GPC is reduced by
70 to 80% (58, 77). This defect was thought to reflect an
inability of the G2A mutant to cluster into specific membrane
microdomains (77). Because the successful completion of
membrane fusion likely involves cooperative interactions
among multiple envelope spikes, a suboptimal concentration at
the site of membrane fusion might be expected to compromise
fusion efficiency, as it does for influenza virus HA (68). How-
ever, this does not appear to be the explanation for the fusion
deficiency in the G2A mutant of GPC. Since the interaction
between the SSP and G2 is critical for membrane fusion activ-
ity (72, 75, 76), we propose that structural changes due to the
absence of myristic acid, or the alanine substitution itself, may
be transduced across the membrane to perturb membrane
fusion. The G2A mutation might equally reduce the efficiency
of fusion by affecting monomer interactions in what are likely
oligomeric envelope glycoprotein spikes (48).
The intrinsic tendency of GPC to cluster into 120- to 160-nm
microdomains on the plasma membrane is largely unaffected
by coexpression of the Z matrix protein. Although the maximal
density of GPC on the membrane, a measure of the tendency
of GPC to cluster, was somewhat reduced upon expression of
Z (peak density, 0.45 units versus 0.6 units without Z), the
overall dimensions of the microdomains were unchanged. Con-
sistent with the lack of effect of Z expression, we could not
detect any significant spatial correlation between plasma mem-
brane-associated Z protein and either individual or clustered
GPC molecules. If Z and GPC are interacting in these exper-
iments, as they must in viral morphogenesis, we could not
detect that association in our analysis.
Because our G1-directed antibody does not distinguish be-
tween the precursor and mature forms of the protein, it is
possible that a biologically relevant interaction between Z and
a subset of mature GPC molecules might be missed. Immature
envelope glycoproteins are thought to be segregated at the cell
surface to ensure that only the functional protein is incorpo-
rated into virion particles (20, 32, 37, 77), and our analysis
would be blind to this distinction. It is also possible that the
interaction between Z and GPC leads to rapid budding of
virus-like particles and that this transient interaction is not
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captured in our images. Alternatively, the association between
Z and GPC during virus assembly may require additional viral
information. This model has been invoked in the assembly of
VSV, in which the G glycoprotein and the M matrix protein
initially cluster onto separate nonraft microdomains on the cell
surface (67). Coalescence of the respective microdomains at
the site of VSV budding is proposed to be initiated by the viral
nucleoprotein (67). In our studies, the labeling of Z was too
sparse to allow us to determine whether or not the arenavirus
matrix protein is itself clustered into microdomains.
It is intriguing that GPC clusters were often detected on
membrane structures reminiscent of nascent budding domains
(Fig. 3) despite the absence of the matrix protein, which is
recognized to mediate the budding of virus-like particles (51,
65). These structures suggest that GPC may contribute to the
establishment of membrane curvature at the assembly plat-
form, either directly or through the recruitment of host cell
proteins.
Our present description of arenavirus GPC assembly onto
discrete membrane microdomains provides further support for
the general notion that virion assembly is often anchored
around specialized patches on the plasma membrane. It is not
known whether these specialized regions of the membrane
exist prior to virus infection or whether they are structured by
the virus proteins. In many viruses, the envelope glycoprotein
appears central in establishing a platform for the recruitment
of virion components, and the virus matrix protein is recog-
nized to be critical for the ultimate budding and release of the
virus particle. In some viruses, the envelope glycoprotein may
itself be able to promote virion budding (17). In others, mem-
brane microdomains used for viral budding are established by
the matrix protein (8, 56). Whereas the logistics of morpho-
genesis appear to differ among viruses, the requirement for a
specialized patch of membrane to nucleate this process is com-
mon to many enveloped viruses and, if susceptible to specific
pharmacologic intervention, may provide a generalized target
for antiviral therapy.
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ADDENDUM IN PROOF
Casabona et al. (J. C. Casabona, J. M. Levingston Macleod,
M. E. Loureiro, G. A. Gomez, and N. Lopez, J. Virol. 83:7029–
7039, 2009) recently reported that coexpression of the arena-
virus nucleoprotein with Z substantially enhances the incorpo-
ration of GPC into virus-like particles. This would be
consistent with our observation that GPC and Z are not sub-
stantially associated at the plasma membrane in the absence of
nucleoprotein.
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